Free Trial
NASDAQ:BIOA

BioAge Labs (BIOA) Stock Price, News & Analysis

BioAge Labs logo
$4.90 -0.32 (-6.13%)
As of 09/19/2025 04:00 PM Eastern

About BioAge Labs Stock (NASDAQ:BIOA)

Advanced

Key Stats

Today's Range
$4.88
$5.29
50-Day Range
$4.12
$5.22
52-Week Range
$2.88
$26.62
Volume
700,303 shs
Average Volume
193,467 shs
Market Capitalization
$175.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioAge Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

BIOA MarketRank™: 

BioAge Labs scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for BioAge Labs.

  • Price to Book Value per Share Ratio

    BioAge Labs has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    11.07% of the float of BioAge Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    BioAge Labs has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.
  • Change versus previous month

  • Dividend Yield

    BioAge Labs does not currently pay a dividend.

  • Dividend Growth

    BioAge Labs does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.07% of the float of BioAge Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    BioAge Labs has a short interest ratio ("days to cover") of 12.5, which indicates bearish sentiment.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for BioAge Labs this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, BioAge Labs insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.82% of the stock of BioAge Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about BioAge Labs' insider trading history.
Receive BIOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioAge Labs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIOA Stock News Headlines

Arizona-made nanochips the new millionaire maker?
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
BioAge Labs to Present at Upcoming Investor Conferences
See More Headlines

BIOA Stock Analysis - Frequently Asked Questions

BioAge Labs' stock was trading at $4.20 at the beginning of the year. Since then, BIOA stock has increased by 16.7% and is now trading at $4.90.

BioAge Labs, Inc. (NASDAQ:BIOA) issued its quarterly earnings data on Wednesday, August, 6th. The company reported ($0.60) EPS for the quarter, missing the consensus estimate of ($0.56) by $0.04.

BioAge Labs (BIOA) raised $198 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 11,000,000 shares at $18.00 per share.

BioAge Labs' top institutional investors include Geode Capital Management LLC (1.26%), Marshall Wace LLP (0.63%), Stonepine Capital Management LLC (0.42%) and Bridgeway Capital Management LLC (0.15%).

Shares of BIOA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/06/2025
Today
9/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BIOA
CIK
1709941
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$71.11 million
Net Margins
N/A
Pretax Margin
-2,045.74%
Return on Equity
-25.39%
Return on Assets
-23.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.21
Quick Ratio
13.21

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.01 per share
Price / Book
0.54

Miscellaneous

Outstanding Shares
35,850,000
Free Float
28,386,000
Market Cap
$175.67 million
Optionable
N/A
Beta
N/A
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:BIOA) was last updated on 9/21/2025 by MarketBeat.com Staff
From Our Partners